SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001739614-23-000052
Filing Date
2023-05-30
Accepted
2023-05-30 16:08:41
Documents
1
Period of Report
2023-05-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1685477312.html 4  
1 FORM 4 wk-form4_1685477312.xml 4 3931
  Complete submission text file 0001739614-23-000052.txt   5340
Mailing Address C/O HERON THERAPEUTICS, INC 4242 CAMPUS POINT COURT, SUITE 200 SAN DIEGO CA 92121
Business Address
MANHARD KIMBERLY (Reporting) CIK: 0001202094 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39452 | Film No.: 23976399

Mailing Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 200 LA JOLLA CA 92037 (858) 795-4220
Inhibrx, Inc. (Issuer) CIK: 0001739614 (see all company filings)

IRS No.: 824257312 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)